Advertisement

Report on adrenochrome monosemicarbazide (carbazochrome) and carbazochrome salicylate

Chapter

Abstract

Adrenochrome is an oxidation product of adrenaline (epinephrine) as shown by Green and Richter (1937). Both compounds are unstable, but Braconier et al. (1943) found that when adrenochrome is combined with monosemicarbazone the resulting compound adrenochrome monosemicarbazide (carbazochrome) is stable. This substance is poorly soluble but becomes much more soluble in the form of a sodium salicylate complex and can be given by intramuscular injection or orally. The official name for this compound is carbazochrome salicylate.

Keywords

Blood Loss Bleeding Time Hemostatic Agent Haemostatic Agent Prolonged Bleeding Time 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bacq Z.M., Charlier R., Philippot E. and Dunon G. (1949) Arch. int. Physiol 57, 295.Google Scholar
  2. Braconier F., LE Bihan H. and Beaudet C. (1943) Arch. int. Pharmacodyn. 69, 181.Google Scholar
  3. Brown W.S. (1958) Control of bleeding after dermabrasion. Northw. Med. (Seattle) 57, 470.Google Scholar
  4. Burke D.E., Pogrund R.S. and Clark W.G. (1960)‘Hemostatic agent in control of bleeding’. Abstract 13th Ann. Meeting of Western Society for Clinical Research, California.Google Scholar
  5. Calnan J. and Innésf. L.F. (1958) Control of bleeding at operation: a trial of adrenochrome monosemicarbazone (Adrenoxyl). Brit. J. plast. Surg. 11, 87.CrossRefGoogle Scholar
  6. Duesberg J.-P. (1947) Le temps de saignement humain selon la technique de Dishoek et Jongkees. Rev. belg. Path. 18, 333.Google Scholar
  7. Durante L.J., Moutsos A., Ambrose R.B., Duncan W.Y., Fleming W., Zinsser H.H. and Phillips L.L. (1962) Postprostatectomy bleeding: analysis of consequences of control by clotting agents and hypothermia. Ann. Surg. 156, 781.PubMedCrossRefGoogle Scholar
  8. Dykes E.R. and Anderson R. (1961) Carbazochrome salicylate as a systemic hemostatic agent in plastic operations. J. Amer. med. Ass., 177, 716.Google Scholar
  9. Forman G.H. and Naylor M.N. (1964) Haemostatic properties of adrenochrome monosemicarbazone in dental surgery. Brit. dent. J. 117, 280.Google Scholar
  10. Green D.E. and Richter D. (1937) Biochem. J. 31, 596.PubMedGoogle Scholar
  11. Hagerty R.F., Zavertnik J.J. and Grimson K.S. (1951) Effect of adrenoxyl on blood loss from surgical wounds. Arch. Surg. 62, 420.Google Scholar
  12. Herve A. and Lecomte J. (1949) Action de la semi-carbazone de l’adrénochrome sur les petechies provoquées par le rayonnement X. Arch. int. Pharmacodyn.Google Scholar
  13. Horne H.W. and Scott J.M. (1970) Intrauterine contraceptive devices: A double-blind study. Fertil. and Steril. 21, 230.Google Scholar
  14. Klemm W.R. and Bolton G.R. (1967) Comparative evaluation of systemic anticoagulants in dogs. Arzneimittel-Forsch. 17, 1573.Google Scholar
  15. Marcus A.J. and Spaet T.H. (1958) Ineffectiveness of adrenosem in pulmonary surgery. J. thorac. Surg. 35, 821.PubMedGoogle Scholar
  16. Patel R.B. (1961) Carbazochrome salicylate in the treatment of pulmonary haemorrhage. J. Indian med. Ass. 36, 327.PubMedGoogle Scholar
  17. Perkins R.E.L. (1957) A clinical investigation of adrenochrome monosemicarbazone sodium salicylate. Oral Surg. 10, 230.PubMedCrossRefGoogle Scholar
  18. Prévost H., Cortereau H. and Parrot J.-L. (1947) Elévation de la resistance capillaire sous l’influence du leucodérivé de l’iodadrenochrome et de la monosemicarbazone de l’adrenochrome. C.R. Soc. Biol. (Paris) 141, 1043.Google Scholar
  19. Roskam J. and Derouaux G. (1944) Arch. int. Pharmacodyn. 69, 348.Google Scholar
  20. Ruddell J.S. (1958) Adrenochrome monosemicarbazone (adrenoxyl). An interim evaluation of its effect in reducing blood loss. Anaesthesia 13, 269.PubMedCrossRefGoogle Scholar
  21. Singhal G.D. (1960) Failure of adrenoxyl as a haemostatic agent in skin graft donor areas. Brit. J. plast. Surg. 12, 362.PubMedCrossRefGoogle Scholar
  22. Swan H.T., Nutt A.B., Jowett G.H., Ferguson W.J.W. and Blackburn E.K. (1961) Monosemicarbazone of adrenochrome (adrenoxyl) and cataract surgery. Effect on capillary resistance and incidence of hyphaema. Brit. J. Ophthal. 45, 415.PubMedCrossRefGoogle Scholar
  23. Thajeb S., Kurkcuoglu M. and Mcelfresh A.E. (1959) The value of systemic hemostatic drugs. A‘double-blind’ evaluation of agents used to increase coagulation during tonsillectomy and adenoidectomy. Arch. Otolaryng. 70, 82.Google Scholar
  24. White N.B., Iatridis P.G. and Ferguson J.H. (1966) Adrenochrome semi-carbazone and lack of in vivo activation of Hageman factor. Amer. J. med. Sci. 251, 668.PubMedCrossRefGoogle Scholar
  25. Zweifach B.W. and Chambers R. (1950) Action of hyaluronidase extracts on capillary wall. Ann. N.Y. Acad. Sci. 52, 1047.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff, P.O.B. 442, The Hague, The Netherlands 1977

Authors and Affiliations

  1. 1.Department of Medical ResearchUniversity of LeuvenBelgium

Personalised recommendations